|1.||Mansel, R E: 4 articles (12/2010 - 07/2004)|
|2.||Goyal, A: 4 articles (12/2010 - 07/2004)|
|3.||ALMANAC Trialists Group: 4 articles (09/2006 - 07/2004)|
|4.||Goyal, Amit: 4 articles (09/2006 - 10/2004)|
|5.||Newcombe, Robert G: 4 articles (09/2006 - 10/2004)|
|6.||Mansel, Robert E: 4 articles (09/2006 - 10/2004)|
|7.||Newcombe, R G: 3 articles (04/2010 - 07/2004)|
|8.||Barthelmes, L: 2 articles (12/2010 - 04/2010)|
|9.||Guttormsen, A B: 2 articles (01/2010 - 01/2010)|
|10.||Nopp, A: 2 articles (01/2010 - 01/2010)|
|1.||Colonic Neoplasms (Colon Cancer)
10/27/2012 - "We observed three features after the injection of Patent Blue V in the intestinal loops: (1) Macroscopically healthy terminal ileum of patients with CD or colon cancer showed thin lymphatic vessels linearly directed toward the mesentery; (2) In mild lesions in which the intestinal wall did not reach 8 mm of thickness, we observed short, wide and tortuous lymphatic vessels directed longitudinally along the intestinal axis toward disease-free areas and then transversally toward the mesentery; and (3) Injection in the severely affected lesions, that had a thickness of the intestinal wall over 10 mm, did not show any feature of lymphatic vessels at least on the subserosal surface. "
09/01/2011 - "A randomized controlled trial was carried out in which patients undergoing resection for colonic cancer were allocated to patent V blue or no patent blue V dye submucosal injection of the operative specimen. "
02/01/2010 - "Sixty-nine patients with biopsy-proven cancer of the colon and rectum underwent SLN mapping according to a protocol involving the ex vivo submucosal and peritumoral injection of 2-4 ml of Patent Blue V dye. "
09/01/2006 - "RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients."
08/01/2004 - "Using Patent Blue V, it is possible to identify the sentinel node in most patients with colon cancer. "
|2.||Breast Neoplasms (Breast Cancer)
05/01/2010 - "Clinically, patent blue V dye has been increasingly used in oncological surgery to identify the sentinel lymph nodes in breast cancer and other malignancies. "
03/01/2010 - "Patent blue V is widely used in the identification of sentinel lymph nodes in patients with breast cancer and other malignancies. "
01/01/2010 - "The dye Patent Blue V (PBV) is increasingly used for staging procedures in operable breast cancer, but is reported to cause adverse reactions. "
03/01/2005 - "Patent blue vital (patent blue V; Laboratoire Guerbet, France) is used to identify the sentinel node during surgery for invasive breast cancer. "
01/01/2005 - "823 breast cancer patients underwent SNB based on lymphoscintigraphy, intraoperative gamma probe detection, and blue dye mapping using 99 mTc-nanocolloid and Patent Blue V injected peritumourally. "
01/01/2010 - "Patent Blue V (PBV) is injected in order to map sentinel nodes during cancer staging procedures. "
05/01/2008 - "Patent Blue V is an inert dye increasingly being used during cancer surgery to identify the sentinel lymph node. "
11/01/2007 - "The day of the intervention, 2.5% patent blue V dye (S.A.L.F: Italy) was injected circumferentially around the tumor. "
09/01/2007 - "Before resection, 2 to 3 ml of Patent Blue V dye was injected subserosally around the tumor. "
11/01/2005 - "A total of 56 open colorectal resections were performed, and Patent Blue V dye was injected under the serosa surrounding the tumor immediately after opening the abdomen. "
11/01/2010 - "[Hypersensitivity reaction after injection of patent blue V dye in saline for sentinal node detection]."
03/01/2010 - "On the basis of our experience of patent blue V allergy, we propose a diagnostic protocol that can be safely and reliably utilised in centres equipped for allergy testing."
03/01/2010 - "We gathered all cases of patent blue V allergy that had been seen and diagnosed in the Department of Allergy, Addenbrooke's Hospital over a 3-year period. "
03/01/2010 - "Individual case reports of allergy to patent blue V have been described in the medical literature since the 1960s. "
07/01/1982 - "[Allergic reactions to patent blue violet: mechanisms, frequency and treatment]."
08/01/2004 - "The aim of this study was to evaluate the use of Patent Blue V for identification of the sentinel node in patients with colon carcinoma. "
09/01/2006 - "The SLN concept in colon carcinoma using Patent Blue V is feasible and accurate. "
12/01/2005 - "Patent blue V is a well-known dye for visualisation of the lymph nodes in a sentinel lymph node biopsy in breast carcinoma. "
08/01/2004 - "From May 2002, 35 patients operated for colon carcinoma underwent lymphatic mapping using Patent Blue V as marker. "
08/01/2004 - "Successful sentinel node identification in colon carcinoma using Patent Blue V."
|1.||patent blue violet (patent blue V)
|4.||iso-sulfan blue (Lymphazurin)
|5.||Methylene Blue (Methylthioninium Chloride)
|6.||Coloring Agents (Dyes)
|7.||Polymethyl Methacrylate (Sol)